Archimedes Tech Spac Partner (ARCI) traded down -0.1 % during a 24 hours period ending at 05:36 PM Central Europe on Monday 26th. One Archimedes Tech Spac Partner stock can currently be bought for about USD 10.04 on popular exchanges. Current supply of Archimedes Tech Spac Partner stocks is 35.3 mn. Archimedes Tech Spac Partner has a current market capitalization of USD 353.7 mn and approximately USD 5.1 mn worth of Archimedes Tech Spac Partner was traded on exchanges in the last 24 hours. Since last month end, Archimedes Tech Spac Partner has traded -0.69 % down. Simple moving average of last 200 days is at USD 10.02. The highest price of past 52 weeks was recorded at USD 10.2 on 08/11/2026. 52 weeks low was at USD 9.83 on 03/30/2026.
Here is how related stocks have performed in the past 24 hours:
K&f Growth Acquisition Cor (KFII) traded down -0.09 % and now trades at USD 10.71. Current market capitalisation for K&f Growth Acquisition Cor is USD 420.4 mn.
Acco Brands (ACCO) traded down -2.35 % and now trades at USD 4.46. Current market capitalisation for Acco Brands is USD 421.9 mn. Acco Brands has a current price to earnings ratio of 7.37.
Advansix (ASIX) traded up 0.19 % and now trades at USD 15.79. Current market capitalisation for Advansix is USD 424.2 mn. Advansix Inc. is slated to participate in a U.S. government‑backed expansion of fertilizer production, receiving support for a modernization project at its Virginia ammonia facility. The initiative, part of a broader federal effort to enhance domestic supply and reduce dependence on imports, will see the company upgrade its existing plant and increase output. The federal program aims to raise overall nitrogen fertilizer capacity and is expected to moderate price pressures once the projects become operational. Advansix’s investment aligns with the administration’s focus on securing the agricultural supply chain and fostering competitive production within North America. The company’s involvement signals its continued commitment to strengthening production capabilities in line with national priorities.
Ovid Therapeutics (OVID) traded down -8.86 % and now trades at USD 2.18. Ovid Therapeutics has a market capitalisation of USD 421.8 mn.
Nathan’s Famous (NATH) traded up 0.11 % and now trades at USD 102.05. Current market capitalisation for Nathan’s Famous is USD 417.8 mn. Nathan’s Famous has a current price to earnings ratio of 21.12.
